Cargando…
Dental management of patients with haemophilia in the era of recombinant treatments: increased efficacy and decreased clinical risk
Haemophilia is a hereditary X-linked recessive disorder caused by a deficiency of either clotting factor VIII (haemophilia A) or IX (haemophilia B). Conventional treatment is currently based on the use of either plasma derived or recombinant coagulation factors. This paper reports on the case of a p...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453434/ https://www.ncbi.nlm.nih.gov/pubmed/30962210 http://dx.doi.org/10.1136/bcr-2018-227974 |